Pricing Log in Create free account
Saturday 7 November 2026 Export RHEP’s income statement to Excel — free account

Adcare Health Systems Inc

RHEP Healthcare Medical Care Facilities

Adcare Health Systems Inc’s revenue for fiscal 2025 (year ended December 2025) was $53.2 million, up 189.9% from fiscal 2024.

Revenue
+143.0%
EPS
+70.6%
Free cash flow
+224.5%
Total debt
−13.0%

Quarter to June 2026, against a year earlier

1.00 0.00 0.00%
Market cap
$5.2M
P/E
0.6×
Fwd P/E
−0.4×
Dividend yield
—
F-score
5/9
Altman Z
−0.93
Beneish M
−0.24
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Bought, $m 0.09
Sold, $m 0.01
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy 2 — — — 1 2 — — — — — —
Sell — — — — — — 1 — — — — —
Insider Ownership 59.52%

Capital & Financial Ratios $m

Size
Market Cap 5.21
Revenue ttm 81.52
Net income ttm 4.07
Free cash flow ttm 6.06
Net debt Q 38.78
Valuation
P/E 0.61
Forward P/E (0.37) (negative: loss-making)
Price / sales 0.05
Forward P/S Powerpack
Price / FCF 0.65
Price / book 0.00
Financial health
Current ratio Q 0.65 (below 1: weak)
Debt / equity Q 14.29 (above 2: weak)
Interest coverage Q (0.38)
Growth
Revenue growth Q +143.03% (above 0%: growing)
Operating income growth Q +57.48% (above 0%: growing)
EPS, this year —
EPS, next year A —
Revenue, next year A +16.15% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A —

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.5×, against a ten-year median of 2.7×; over the ten years it ranged from 0.5× in 2026 to 5.6× in 2016.
P/S against its own 10 years 0.51%
10-year low 10-year high
EV/Sales against its own 10 years 0.51%
10-year low 10-year high
EV/FCF against its own 10 years 11.80%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 4 2 5 4
Receivables 1 3 8 10
Inventory — — 1 2
Other 11 10 — —
18 7 16 18
2023 2024 2025 Q'26
Payables 2 4 7 7
ST’ Debt — 10 8 8
Other — 1 1 2
7 20 24 27

Compound Annual Growth %

10y 5y 3y
Sales 11.19% 24.77% 13.95%
Cash Flow 0.00% 0.00% 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value (36.13%) (49.94%) (54.54%)

EPS $

Mar Jun Sep Dec Year
’26 (0.29) (0.20) — — —
’25 (0.94) (0.68) 1.17 0.95 1.09
’24 (0.52) (0.38) (0.52) (0.31) (1.73)
’23 (2.28) (0.36) (0.52) (0.13) 21.05
’22 (2.89) (2.02) (1.48) (2.54) (8.93)
’21 (1.32) (1.62) (1.27) (1.66) (5.87)
’20 (1.34) (1.09) (1.38) (1.93) (5.74)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 21 24 — — —
’25 7 10 15 21 53
’24 4 4 4 6 18
’23 4 5 4 5 17
’22 7 8 11 10 36
’21 7 6 7 6 27
’20 5 5 5 4 18
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (1) 1 — — —
’25 0 1 (2) (1) (2)
’24 1 1 0 1 2
’23 3 0 1 0 4
’22 (2) (1) 1 (1) (4)
’21 2 0 2 1 5
’20 0 0 1 0 1
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (1) 1 — — —
’25 0 0 (2) 9 7
’24 1 0 0 1 1
’23 3 0 0 0 3
’22 (2) (1) 1 (2) (4)
’21 2 0 2 1 5
’20 0 0 1 0 1
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 28 25 22 20 18 27 36 17 18 53 82 +7.6% — — — —
Gross margin, % 100.00 97.48 97.11 96.72 96.16 62.85 41.34 50.05 48.50 28.96 29.91 (71.0) pt
EBT 6 1 (12) 5 (1) (1) (7) (4) (3) 3 4 (5.9%)
EBT margin, % 21.02 2.01 (54.46) 24.21 (3.44) (4.43) (19.11) (22.65) (17.55) 6.34 4.99 (14.7) pt
Net income (7) (1) (12) 6 (1) (1) (7) (4) (3) 3 4 n/m
Per share, $
Per share, $ Revenue 16.66 15.21 13.15 11.93 10.41 15.39 20.23 9.14 9.87 18.95 20.75 +1.4%
Earnings (8.88) (5.16) (11.86) (2.07) (5.74) (5.87) (8.93) (2.07) (1.73) 1.09 1.63 n/m
Cash flow (2.06) 3.11 0.80 1.42 0.77 2.82 (2.02) 1.98 1.05 (0.81) (0.65) (9.9%)
Capex 10.18 (1.34) (0.20) 1.56 (0.27) (0.07) (0.16) (0.51) (0.29) 3.25 2.20 (11.9%)
Free cash flow 8.12 1.77 0.60 2.98 0.50 2.75 (2.18) 1.47 0.76 2.45 1.54 (12.5%)
Book value (22.90) 10.81 3.67 6.96 6.58 6.00 2.09 0.10 (1.57) 0.12 0.76 n/m
Shares, m 2 2 2 2 2 2 2 2 2 3 3 +6.0%
Valuation, ×
Valuation, × P/E 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.56 0.61 0.3
P/S 1.12 0.15 0.12 0.12 0.34 0.29 0.15 0.23 0.16 0.07 0.05 0.3
P/B 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0
EV/Sales 3.31 2.69 3.58 2.47 3.50 2.22 1.56 2.52 2.74 0.79 0.52 2.5
EV/FCF 6.78 23.10 78.13 9.89 72.81 12.39 (14.48) 15.72 35.50 6.13 7.05 24.6
Cash, $m
Cash, $m Operating cash flow (3) 5 1 2 1 5 (4) 4 2 (2) (3) (4.5%)
Capex 17 (2) 0 3 0 0 0 (1) (1) 9 9 (6.6%)
Free cash flow 13 3 1 5 1 5 (4) 3 1 7 6 (7.2%)
Balance, $m
Balance, $m Working capital (5) (15) 1 3 5 4 0 11 (14) (8) (9) +5.6%
Net debt 60 64 101 47 55 51 51 39 47 39 39 (4.9%)
Shareholders’ equity (38) 18 6 12 11 10 4 0 (3) 0 3 n/m
Returns, %
Returns, % ROA (10.25) (7.61) (19.20) (3.26) (8.73) (9.53) (18.21) 60.43 (5.25) 4.75 6.90 +15.0 pt
ROIC 12.63 3.94 (0.46) 5.78 2.15 2.57 (7.84) (1.32) 0.23 2.68 2.35 (9.9) pt
ROE 47.90 20.85 39.43 6.54 18.99 19.70 28.65 (101.89) 15.78 (16.73) (21.71) (64.6) pt
People
People Employees 19 16 16 17 16 15 10 107 256 731 — +50.0%
Revenue/emp, $m 1.45 1.57 1.38 1.18 1.10 1.78 3.59 0.16 0.07 0.07 — (28.3%)
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 25 Oct 2026

Adcare Health Systems Inc vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
CCEL Cryo-Cell International Inc. $39.9M — (loss-making) 65.1× −0.02% (below 0%: shrinking) +77.78% (above 0%: growing) −58.37% (below 0%: shrinking) 79.38% 28.04% Compare
BTMD biote Corp. $37.4M 6.6× — (loss-making) −9.48% (below 0%: shrinking) n/m −174.16% (below 0%: shrinking) 65.38% (7.93%) Compare
PIII P3 Health Partners Inc. $28.1M — (loss-making) — +8.60% (above 0%: growing) n/m −272.24% (below 0%: shrinking) 22.26% 10.67% Compare
DCGO DocGo Inc. $24.1M — (loss-making) — (loss-making) −8.70% (below 0%: shrinking) n/m −132.28% (below 0%: shrinking) 30.52% (24.41%) Compare
CCM Concord Medical Services Holdings Limited $10.0M — (loss-making) — (loss-making) +37.65% (above 0%: growing) n/m −281.45% (below 0%: shrinking) (13.15%) 0.00% Compare
AMS American Shared Hospital Services $7.8M — (loss-making) 1.8× +19.22% (above 0%: growing) n/m +195.82% (above 0%: growing) 17.00% (7.22%) Compare
RHEP Adcare Health Systems Inc $5.2M 0.6× — (loss-making) +143.03% (above 0%: growing) n/m +224.45% (above 0%: growing) 31.50% (0.88%)
SYRA Syra Health Corp. $1.1M 14.7× — +51.50% (above 0%: growing) n/m +235.76% (above 0%: growing) 46.34% 11.73% Compare
NVOS Novo Integrated Sciences, Inc. $730.0K — (loss-making) — (loss-making) −6.74% (below 0%: shrinking) n/m −111.85% (below 0%: shrinking) 51.21% (87.60%) Compare
Median of peers $17.1M — — +4.29% — −122.06% 38.43% (3.61%)

All 51 Medical Care Facilities stocks →

Pay and ownership Proxy statement filed 2 October 2026

Ownership

Directors and executive officers, together 17.96%
Steven J. Baileys 11.85%
Charles Frischer 9.84%
Bradley L. Radoff and the Radoff Family Foundation 8.32%
Brent S. Morrison 5.91%
Robert M. Thornton, Jr. 5.78%
Steven L. Martin 5.62%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Adcare Health Systems Inc (RHEP) Latest News

19 Aug

Impact 3 ·

20 May

Impact 3 · · GlobeNewswire

4 May

Impact 3 · · GlobeNewswire

7 Apr

Impact 4 · · GlobeNewswire

1 Dec

Impact 3 · · GlobeNewswireMT NewswiresMT NewswiresMT NewswiresBarchartMT NewswiresMT Newswires

20 Nov

Impact 4 · · GlobeNewswire

10 Nov

Impact 3 · · GlobeNewswire

17 Sep

Impact 3 · · GlobeNewswire

21 Aug

Impact 3 ·

14 Aug

Impact 3 · · GlobeNewswire

4 Aug

Impact 4 · · Business Wire
Impact 4 ·

29 Jul

Impact 3 ·

28 Jul

Impact 4 · · GlobeNewswire
Impact 3 ·

25 Jul

Impact 4 · · GlobeNewswire

24 Jul

Impact 3 ·

15 Apr

Impact 4 ·

14 Apr

Impact 4 · · GlobeNewswire

30 Jan

Impact 3 · · GlobeNewswire

6 Jan

Impact 4 ·

26 Nov

Impact 3 · · GlobeNewswire

11 Nov

Impact 3 ·

8 Apr

Impact 4 · · GlobeNewswire

17 Nov

Impact 3 · · GlobeNewswire

31 Aug

Impact 4 · · GuruFocus.com

23 Aug

Impact 4 · · GlobeNewswire

3 Aug

Impact 3 · · GlobeNewswire

6 Jul

Impact 4 · · GlobeNewswire

3 Jul

Impact 3 · · GlobeNewswire
stockrow.com/RHEP · Data as of Oct 25, 2026 · For information only; not investment advice. · © 2026 stockrow.com